VIA Folio is pleased to announce that it has processed the closing of Myomo’s Reg A+ IPO, the first of its kind to be traded on a national exchange. Read more >>
Chronix Biomedical, Inc., a developer of novel cancer blood-based molecular diagnostics, announces the publication of positive results of a…
read moreButton batteries are the lifeblood of modern portable electronics, but they can also be death traps for small children….
read moreFutureFuel.io, a SaaS platform connecting employers, employees, and student loan servicers, is pushing to “crush” student debt. Read more…
read moreA teen who is legally blind from Bucks County is getting help from electronic glasses that help to improve…
read moreOne of the most important inventions is the Daktari CD4 System, a portable device designed to improve treatment for…
read moreCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic,…
read moreMyomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE…
read moreBenefit first partnered with ZoomSystems in 2013 to create Glam up & away. ZoomSystems is the global leader in…
read moreEmovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support…
read moreDaktari Diagnostics, a company focused on making “Anywhere. Care.™” a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today…
read more